Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting
- PMID: 19787716
- DOI: 10.1002/jmri.21926
Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting
Abstract
Purpose: To demonstrate 4.7 Tesla (T) imaging methods for visualizing lesions in multiple sclerosis in the human brain using phase susceptibility-weighting and T2 weighting.
Materials and methods: Seven patients with relapsing-remitting multiple sclerosis were imaged at 4.7T using three-dimensional (3D) susceptibility-weighted imaging (SWI) with 0.90 mm(3) voxel volumes, and with 2D T2-weighted fast spin echo (T2WFSE) with 0.34 mm(3) voxels and 1.84 mm(3) voxels. The visibility of MS lesions at 4.7T with phase SWI and T2WFSE was assessed by independent lesion counts made by an experienced neuroradiologist, and by quantitative measures.
Results: High resolution T2WFSE at 4.7T provided excellent depiction of hyperintense lesions. When combined with phase SWI, 124 total lesions were identified of which 18% were only visible on phase SWI and not on T2WFSE. The phase lesions had a mean phase shift relative to local background of -11.15 +/- 5.97 parts per billion.
Conclusion: Imaging at 4.7T can provide both high quality, high resolution T2WFSE and SWI for visualization of lesions in multiple sclerosis. Phase susceptibility-weighting can identify additional lesions that are not visible with high resolution T2WFSE.
(c) 2009 Wiley-Liss, Inc.
Similar articles
-
Three-dimensional magnetic resonance observation of cartilage repair tissue (MOCART) score assessed with an isotropic three-dimensional true fast imaging with steady-state precession sequence at 3.0 Tesla.Invest Radiol. 2009 Sep;44(9):603-12. doi: 10.1097/RLI.0b013e3181b5333c. Invest Radiol. 2009. PMID: 19692843 Clinical Trial.
-
Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI.J Magn Reson Imaging. 2011 Mar;33(3):543-9. doi: 10.1002/jmri.22452. J Magn Reson Imaging. 2011. PMID: 21563237
-
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.Arch Neurol. 2008 Feb;65(2):236-43. doi: 10.1001/archneurol.2007.51. Arch Neurol. 2008. PMID: 18268194
-
Imaging of the musculoskeletal system in vivo using ultra-high field magnetic resonance at 7 T.Invest Radiol. 2009 Sep;44(9):613-8. doi: 10.1097/RLI.0b013e3181b4c055. Invest Radiol. 2009. PMID: 19652609 Review.
-
Clinical applications of neuroimaging with susceptibility-weighted imaging.J Magn Reson Imaging. 2005 Oct;22(4):439-50. doi: 10.1002/jmri.20404. J Magn Reson Imaging. 2005. PMID: 16163700 Review.
Cited by
-
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.Magn Reson Med. 2015 Jan;73(1):82-101. doi: 10.1002/mrm.25358. Epub 2014 Jul 17. Magn Reson Med. 2015. PMID: 25044035 Free PMC article. Review.
-
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.MAGMA. 2016 Jun;29(3):543-57. doi: 10.1007/s10334-016-0560-5. Epub 2016 Apr 25. MAGMA. 2016. PMID: 27112155 Free PMC article.
-
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.Ther Adv Neurol Disord. 2015 Mar;8(2):59-70. doi: 10.1177/1756285615572953. Ther Adv Neurol Disord. 2015. PMID: 25941537 Free PMC article.
-
Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis?Neuroradiology. 2011 May;53(5):311-7. doi: 10.1007/s00234-010-0736-z. Epub 2010 Jun 29. Neuroradiology. 2011. PMID: 20585764
-
A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design.Diagnostics (Basel). 2021 Dec 30;12(1):77. doi: 10.3390/diagnostics12010077. Diagnostics (Basel). 2021. PMID: 35054244 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical